AQR Capital Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$510K Buy
66,547
+19,922
+43% +$136K ﹤0.01% 3109
2025
Q4
$92.3K Sell
46,625
-57,154
-55% -$129K ﹤0.01% 3466
2025
Q3
$255K Sell
103,779
-55,383
-35% -$143K ﹤0.01% 3157
2025
Q2
$420K Buy
159,162
+114,714
+258% +$308K ﹤0.01% 2708
2025
Q1
$134K Buy
44,448
+29,297
+193% +$88.8K ﹤0.01% 2960
2024
Q4
$38.8K Sell
15,151
-39,736
-72% -$166K ﹤0.01% 2825
2024
Q3
$204K Buy
54,887
+6,435
+13% +$29.8K ﹤0.01% 2558
2024
Q2
$306K Buy
48,452
+29,727
+159% +$196K ﹤0.01% 2259
2024
Q1
$101K Buy
+18,725
New +$84.8K ﹤0.01% 2338
2021
Q1
Sell
-45,338
Closed -$604K 2225
2020
Q4
$604K Sell
45,338
-15,555
-26% -$150K ﹤0.01% 1718
2020
Q3
$422K Buy
+60,893
New +$607K ﹤0.01% 1800

Other funds holding IBRX